Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02977468
Brief Title: Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (Pembro/IORT)

First Submitted : November 28, 2016
First Submitted that Met QC Criteria : November 28, 2016
First Posted : November 30, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 31, 2019
Last Update Posted : February 4, 2019